Literature DB >> 1452655

Polymerase chain reaction-based detection of Trypanosoma cruzi DNA in serum.

G Russomando1, A Figueredo, M Almirón, M Sakamoto, K Morita.   

Abstract

DNAs prepared from chagasic patients' sera were amplified by the polymerase chain reaction using oligonucleotide primers which anneal specifically to a highly repetitive sequence of Trypanosoma cruzi nuclear DNA. Samples from both acutely and chronically infected patients yielded positive results by this method. No significant difference was observed when either whole blood or serum samples of the patients were used. These results indicate that serum instead of whole-blood samples could be used for polymerase chain reaction-based detection of T. cruzi in field studies without the need of applying any special chemical treatment to the specimens. This would represent a considerable advantage due to the easier handling and transportation of serum as compared with whole-blood samples, especially in tropical climates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452655      PMCID: PMC270543          DOI: 10.1128/jcm.30.11.2864-2868.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns.

Authors:  M B Reyes; M Lorca; P Muñoz; A C Frasch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

2.  Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease.

Authors:  H A Avila; D S Sigman; L M Cohen; R C Millikan; L Simpson
Journal:  Mol Biochem Parasitol       Date:  1991-10       Impact factor: 1.759

3.  Quantification of Trypanosoma cruzi parasitaemia by direct micromethod.

Authors:  A R de Arias; E A Ferro
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

4.  Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction.

Authors:  D R Moser; L V Kirchhoff; J E Donelson
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

5.  IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis.

Authors:  T M Chiller; M A Samudio; G Zoulek
Journal:  Am J Trop Med Hyg       Date:  1990-12       Impact factor: 2.345

6.  Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas' disease.

Authors:  N R Sturm; W Degrave; C Morel; L Simpson
Journal:  Mol Biochem Parasitol       Date:  1989-03-15       Impact factor: 1.759

7.  Cardiomyopathy in Cebus apella monkeys experimentally infected with Trypanosoma cruzi.

Authors:  I M Rosner; J Bellasai; A Schinini; T Rovira; A R de Arias; E A Ferro; E Ferreira; G Velazquez; M I Monzón; M Maldonado
Journal:  Trop Med Parasitol       Date:  1989-03

8.  Acute Chagas' disease in non-human primates. 1. Chronology of clinical events, clinical chemistry, ECG, radiology, parasitemia, and immunological parameters in the Cebus apella monkey.

Authors:  J M Rosner; A Schinini; T Rovira; A de Arias; G Velásquez; M Idalia Monzón; M Maldonado; E A Ferro; R Galeano
Journal:  Trop Med Parasitol       Date:  1988-03
  8 in total
  14 in total

Review 1.  Innovative low cost technologies for biomedical research and diagnosis in developing countries.

Authors:  Josefina Coloma; Eva Harris
Journal:  BMJ       Date:  2004-11-13

2.  Natural Chagas disease in four baboons.

Authors:  Jeff T Williams; Edward J Dick; John L VandeBerg; Gene B Hubbard
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

3.  Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods.

Authors:  Juan David Ramírez; Felipe Guhl; Eufrosina Setsu Umezawa; Carlos A Morillo; Fernando Rosas; Jose A Marin-Neto; Silvia Restrepo
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

4.  Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi.

Authors:  L V Kirchhoff; J R Votava; D E Ochs; D R Moser
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina.

Authors:  Ana María De Rissio; Adelina Rosa Riarte; Miriam Martín García; Mónica Inés Esteva; Marta Quaglino; Andrés Mariano Ruiz
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

6.  Trypanosoma cruzi lineages detected in congenitally infected infants and Triatoma infestans from the same disease-endemic region under entomologic surveillance in Paraguay.

Authors:  Florencia del Puerto; Zunilda Sánchez; Eva Nara; Graciela Meza; Berta Paredes; Elizabeth Ferreira; Graciela Russomando
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

Review 7.  DNA probes and PCR for diagnosis of parasitic infections.

Authors:  J B Weiss
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis.

Authors:  H A Avila; J B Pereira; O Thiemann; E De Paiva; W DeGrave; C M Morel; L Simpson
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Identification and detection of Trypanosoma cruzi by using a DNA amplification fingerprint obtained from the ribosomal intergenic spacer.

Authors:  N González; I Galindo; P Guevara; E Novak; J V Scorza; N Añez; J F Da Silveira; J L Ramírez
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

Review 10.  Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.

Authors:  Facundo Garcia-Bournissen; Jaime Altcheh; Norberto Giglio; Guido Mastrantonio; Carlos Omar Della Védova; Gideon Koren
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.